News

The Salk Institute and former Salk scientist Beverly Emerson said they have settled her lawsuit, the last of three gender discrimination cases filed by female researchers in 2017. "The Salk Institute and Dr. Beverly Emerson announce that they … […]

Arena Pharmaceuticals will get $800 million cash upfront in a mammoth global drug commercialization deal announced Thursday. The San Diego biomedical company licensed its lung disease drug, ralinepag, to North Carolina?s United Therapeutics Corp. I… […]

Synthorx, a La Jolla biotech developing cancer therapies from partly synthetic life, is seeking $100 million in an initial public offering. The Scripps Research spinoff made the filing with the Securities and Exchange Commission on Tuesday. It seek… […]

Challenging the popular but pricey EpiPen, San Diego?s Adamis Pharmaceuticals is readying its own emergency allergy medication for sale. Called Symjepi, the product is a pre-filled syringe of epinephrine, used to counteract life-threatening allergi… […]

Muscular and possessing a killer handshake, Bradley Couch fit right in with the athletic set of bicyclists taking part in Saturday?s Padres Pedal the Cause, an annual fundraiser to support cancer patients and research in San Diego. Surprisingly, Co… […]

Henrietta Lacks? ?immortal cells? contributed enormously to the progression of scientific discovery, but Lacks, a poor, black woman who died from cervical cancer in 1951 months after her cells were harvested, never personally benefited from or consente… […]

Twelve years ago, Eric Dudl had begun his postdoctoral research at Sanford Burnham Prebys Biomedical Research Institute (SBP) when he received shocking news. He had the same disease he was working to eradicate: cancer.?

Despite his diagnosis, Eric did… […]

Forty-five scientists, staff and supporters of Sanford Burnham Prebys Medical Discovery Institute (SBP) ran, walked and biked to raise critical funding for local cancer research at the 2018 Padres Pedal the Cause fundraising event. The team joined more… […]

SAN DIEGO–(BUSINESS WIRE)–Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, today announced a definitive agreement by which it will be acquired by Genentech, a member of the Roche […]